Symons Julian A.
SEC insider (Form 3/4/5 filer). CIK 0001824727. Officer at Aligos Therapeutics, Inc. (ALGS). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 9, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Symons Julian A. has filed insider reports for
- Aligos Therapeutics, Inc. (ALGS): Officer, See Remarks
Symons Julian A.
CIK: 0001824727
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aligos Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 9, 2026ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
23.3K shares- - Jul 16, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
16K shares- - Feb 28, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.7K shares- - Sep 4, 2024ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 9, 2026 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 23,310 | - | - | Direct |
| Jul 16, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 16,000 | - | - | Direct |
| Feb 28, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,693 | - | - | Direct |
| Sep 4, 2024 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,880 | - | - | Direct |
1-4 of 4 transactions